Janus Henderson further downgrades PharmEasy valuation to $ 2.7 billion

Asset management company Janus Henderson has further downgraded its investments in the online pharmacy, PharmEasy’s parent entity, API Holdings, The Economic Times (ET) reported citing details of regulatory filings with the US Securities and Exchange Commission (SEC).

Janus Henderson valued its investments in the pharmacy startup at $2.7 billion as of March 31, 2023, which is less than half of what it was in September 2021 when it stood at $5.6 billion. The latest valuation estimates were notified to the US securities regulator in a May 30 filing, the report said.